TCL Archive In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER March 20, 1992
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light December 5, 2014
TCL Archive In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs January 17, 1992
TCL Archive NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells. November 23, 2007